Gupta Samir K相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Outcomes Following Antifungal Treatment for Candida Growth in Bile Cultures Collected During Endoscopic Retrograde Cholangiopancreatography

内镜逆行胰胆管造影术中采集的胆汁培养物中念珠菌生长的抗真菌治疗后的结果

期刊:Journal of Fungi

doi:10.3390/jof12030208

Charpentier, Grace; Smith, Kevin Andrew; Slaven, James E; Emeli, Theresa O; Susler, Rachel G; Chehab, Hamed; Gromski, Mark A; Khan, Haseeba; Gupta, Samir K; Barros, Nicolas

发表日期：2026

文献求助收藏

Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV

影响全球艾滋病毒感染者心血管疾病预防队列中心血管疾病事件风险的因素

期刊:Clinical Infectious Diseases

影响因子:7.3

doi:10.1093/cid/ciaf210

Grinspoon, Steven K; Watanabe, Maya; Ribaudo, Heather J; Bloomfield, Gerald S; Fichtenbaum, Carl J; Umbleja, Triin; Chu, Sarah M; Fitch, Kathleen V; Diggs, Marissa R; Zhao, Sophia; Looby, Sara E; Currier, Judith S; Aberg, Judith A; Malvestutto, Carlos D; Erlandson, Kristine M; Martinez, Esteban; Asupoto, Olabimpe; Gupta, Samir K; Lopez-Bernaldo de Quiros, Juan C; Nixon, Daniel; Bedimo, Roger; Lu, Michael T; Douglas, Pamela S; Zanni, Markella V

心血管疾病

发表日期：2025

文献求助收藏

P-581. Racial/Ethnic Disparities of Renal Outcomes in People with HIV (PWH) on Tenofovir Alafenamide (TAF) Based Antiretroviral Treatment (ART) Regimens in the Real World

P-581. 真实世界中接受替诺福韦艾拉酚胺（TAF）类抗逆转录病毒治疗（ART）方案的HIV感染者（PWH）肾脏结局的种族/民族差异

期刊:Open Forum Infectious Diseases

影响因子:3.8

doi:10.1101/2025.11.20.25340714

Tian, Ling; Geng, Siyi; Li, Xingyan; Jaeger, Byron C; Dorans, Kirsten S; Chen, Jing; Anderson, Amanda H; Whelton, Paul K; Krousel-Wood, Marie; He, Jiang; Bundy, Joshua D; Gupta, Samir K; Canada, Robert; Naik, Sarjita; Huang, Xiwen; Weinberg, Amy; Temme, Lauren; Tao, Li; Chiang, Betty; Chokkalingam, Anand; Slim, Jihad

发表日期：2025

文献求助收藏

Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials

B/F/TAF 在 ≥ 50 岁且未接受过治疗的 HIV 感染者和病毒学抑制患者中的疗效和安全性：来自六项 3 期临床试验的综合分析

期刊:BMC Infectious Diseases

doi:10.1186/s12879-025-11476-3

Kityo, Cissy M; Gupta, Samir K; Kumar, Princy N; Weinberg, Amy R; Gandhi-Patel, Bhumi; Liu, Hui; Hindman, Jason T; Rockstroh, Jürgen K

发表日期：2025

文献求助收藏

The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis

多替拉韦+利匹韦林固定剂量组合在血液透析中的稳态药代动力学

doi:10.1097/QAD.0000000000004071

Gupta, Samir K; Friedman, Allon N; Desta, Zeruesenay

发表日期：2025

文献求助收藏

MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics

HIV感染者合并代谢相关肝病（MASLD）与较高的心血管代谢风险相关，这已通过改变的晚期脂蛋白谱和靶向代谢组学得到证实。

期刊:Lipids in Health and Disease

影响因子:4.2

doi:10.1186/s12944-024-02317-4

Lin, Kung-Hung; Vilar-Gomez, Eduardo; Corey, Kathleen E; Connelly, Margery A; Gupta, Samir K; Lake, Jordan E; Chalasani, Naga; Gawrieh, Samer

发表日期：2024

文献求助收藏

Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial

HIV感染者服用匹伐他汀与安慰剂预防心血管疾病的糖尿病风险因素：一项随机试验

期刊:Annals of Internal Medicine

doi:10.7326/ANNALS-24-00944

Fitch, Kathleen V; Zanni, Markella V; Manne-Goehler, Jennifer; Diggs, Marissa R; Gattu, Arijeet K; Currier, Judith S; Bloomfield, Gerald S; Hsiao, Chiu-Bin; Gupta, Samir K; Aberg, Judith A; Malvestutto, Carlos D; Fichtenbaum, Carl J; Lu, Michael T; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K

心血管疾病

发表日期：2024

文献求助收藏

Immune checkpoints and pancreatic beta cell dysfunction in HIV

HIV感染中的免疫检查点和胰岛β细胞功能障碍

doi:10.1097/QAD.0000000000003932

Pryke, Luke A; Liu, Ziyue; Khaitan, Alka K; Sims, Emily K; Gupta, Samir K

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study

HIV感染者脂肪肝和肝纤维化的负担：一项美国多中心横断面研究

期刊:Hepatology

影响因子:15.8

doi:10.1097/HEP.0000000000000313

Gawrieh, Samer; Lake, Jordan E; Debroy, Paula; Sjoquist, Julia A; Robison, Montreca; Tann, Mark; Akisik, Fatih; Bhamidipalli, Surya S; Saha, Chandan K; Zachary, Kimon; Robbins, Gregory K; Gupta, Samir K; Chung, Raymond T; Chalasani, Naga; Corey, Kathleen E

发表日期：2023

文献求助收藏

Preswitch Regimens Influence the Rate of Weight Gain After Switch to Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir (TLD): Study From an East African Cohort

转换前用药方案影响转换至富马酸替诺福韦二吡呋酯、拉米夫定和多替拉韦（TLD）后的体重增加速度：一项来自东非队列的研究

期刊:Open Forum Infectious Diseases

影响因子:3.8

doi:10.1093/ofid/ofad581

Bourgi, Kassem; Ofner, Susan; Musick, Beverly; Wools-Kaloustian, Kara; Humphrey, John M; Diero, Lameck; Yiannoutsos, Constantin T; Gupta, Samir K

发表日期：2023

文献求助收藏